United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1,025 out of 156,020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28,461 | 30,479 |
| Total Cites | 2,279 | 2,352 |
| H-index | 24 | 26 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 205 | 214 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 1,886 | 1,931 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,690 | 1,707 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.38 |
| Self-Citation Percentage |
3.10%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1,470 out of 135,958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43,023 | 45,512 |
| Total Cites | 1,684 | 1,794 |
| H-index | 20 | 21 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 191 | 194 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 1,369 | 1,437 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1,275 | 1,305 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
6.13%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1,677 out of 117,692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51,423 | 57,369 |
| Total Cites | 1,349 | 1,434 |
| H-index | 19 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 188 | 206 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 1,047 | 1,106 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,051 | 1,076 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
5.93%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2,569 out of 103,235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84,022 | 83,859 |
| Total Cites | 808 | 915 |
| H-index | 16 | 18 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 182 | 196 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 509 | 577 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 675 | 700 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.31 |
| Self-Citation Percentage |
11.69%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.